TROAP promotes esophageal squamous cell carcinoma progression via the PI3K/AKT pathway

被引:0
|
作者
Liqiang Shi [1 ]
Yajie Zhang [1 ]
Cong Yang [2 ]
Yaxin Wang [1 ]
Yichao Han [1 ]
Chuanyin Li [3 ]
Yun Yang [4 ]
Dong Dong [1 ]
Mingyuan Du [1 ]
Hecheng Li [1 ]
机构
[1] Ruijin Hospital,Department of Thoracic Surgery
[2] Shanghai Jiao Tong University School of Medicine,Cancer Center, School of Medicine, Shanghai Tenth People’s Hospital
[3] Tongji University,Department of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affi
[4] Zhejiang University School of Medicine,Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Sciences, Hangzhou Institute for Advanced Study
[5] University of Chinese Academy of Sciences,undefined
关键词
TROAP; Esophageal squamous cell carcinoma; Malignant phenotype; PI3K/AKT;
D O I
10.1007/s00432-025-06200-2
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Baicalein induces apoptosis in esophageal squamous cell carcinoma cells through modulation of the PI3K/Akt pathway
    Zhang, Hong-Bo
    Lu, Ping
    Guo, Qing-Yin
    Zhang, Zhen-Hua
    Meng, Xiang-Yu
    ONCOLOGY LETTERS, 2013, 5 (02) : 722 - 728
  • [32] The PI3K/AKT Pathway and Renal Cell Carcinoma
    Huifang Guo
    Peter German
    Shanshan Bai
    Sean Barnes
    Wei Guo
    Xiangjie Qi
    Hongxiang Lou
    Jiyong Liang
    Eric Jonasch
    Gordon B.Mills
    Zhiyong Ding
    Journal of Genetics and Genomics, 2015, 42 (07) : 343 - 353
  • [33] AKAP12 inhibits esophageal squamous carcinoma cell proliferation, migration, and cell cycle via the PI3K/AKT signaling pathway
    Li, Xingyi
    Dong, Hao
    Zheng, Yifan
    Ding, Shengguang
    Li, Yan
    Li, Hefei
    Huang, Haitao
    Zhong, Congjun
    Xie, Tian
    Xu, Yiming
    MOLECULAR AND CELLULAR PROBES, 2023, 72
  • [34] The PI3K/AKT Pathway and Renal Cell Carcinoma
    Guo, Huifang
    German, Peter
    Bai, Shanshan
    Barnes, Sean
    Guo, Wei
    Qi, Xiangjie
    Lou, Hongxiang
    Liang, Jiyong
    Jonasch, Eric
    Mills, Gordon B.
    Ding, Zhiyong
    JOURNAL OF GENETICS AND GENOMICS, 2015, 42 (07) : 343 - 353
  • [35] Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma via the PI3K/AKT pathway
    Dong-Xin Hu
    Qi-Feng Sun
    Lin Xu
    Hong-Da Lu
    Fan Zhang
    Zhen-Miao Li
    Ming-Yan Zhang
    World Journal of Gastroenterology, 2022, 28 (04) : 464 - 478
  • [36] Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma via the PI3K/AKT pathway
    Hu, Dong-Xin
    Sun, Qi-Feng
    Xu, Lin
    Lu, Hong-Da
    Zhang, Fan
    Li, Zhen-Miao
    Zhang, Ming-Yan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (04) : 464 - 478
  • [37] IMMT promotes hepatocellular carcinoma formation via PI3K/AKT/mTOR pathway
    Wang, Jiabei
    Zhang, Yunguang
    Sun, Linmao
    Liu, Yao
    ONCOLOGIE, 2023, 25 (06) : 691 - 703
  • [38] IL-1β promotes esophageal squamous cell carcinoma growth and metastasis through FOXO3A by activating the PI3K/AKT pathway
    Chen, Shuangshuang
    Yang, Ying
    Zheng, Zhaoyang
    Zhang, Man
    Chen, Xixian
    Xiao, Nan
    Liu, Hongchun
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [39] Paraoxonase 3 promotes cell proliferation and metastasis by PI3K/Akt in oral squamous cell carcinoma
    Zhu, Lili
    Shen, Yiyin
    Sun, Wei
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 85 : 712 - 717
  • [40] Saikosaponin D suppresses esophageal squamous cell carcinoma via the PI3K-AKT signaling pathway
    Duan, Qiong
    Wang, Mingxiao
    Cui, Zhenting
    Ma, Jianxin
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, : 6059 - 6070